![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » NICE Endorses Boston Scientific’s Battery Powered CRT-D Devices
NICE Endorses Boston Scientific’s Battery Powered CRT-D Devices
![](https://www.fdanews.com/ext/resources/test/Device_Images6/EU_StarsCircle_Blue.gif?t=1488461364&width=430)
The National Institute for Health and Care Excellence (NICE) has published medical technology guidance recommending the use of Boston Scientific’s cardiac resynchronization therapy defibrillators (CRT-D) powered by EnduraLife battery technology, for treating patients with heart failure.
NICE concluded that the extended battery life observed with Boston Scientific EnduraLife-powered CRT-Ds is likely to reduce the number of avoidable replacement procedures a patient may have to undergo.
The NICE medical technologies advisory committee found that 16 independent clinical and economic studies supported adoption and concluded that the EnduraLife-powered CRT-Ds have longer battery life compared with other CRT-Ds reviewed.
The EnduraLife battery has nearly twice the capacity of standard batteries and it is smaller. — Cynthia Jessup
Upcoming Events
-
21Oct